IGF-1 LR3 Compounds (Peptide Lyophilized Vial)

IGF-1 LR3 is a modified long-acting analog of insulin-like growth factor 1. It is engineered for altered binding behavior and extended activity compared with native IGF-1, which is why it is treated as a distinct research molecule. On a site like this, it should be described as a research peptide tied to growth and metabolic signaling studies.

Researchers usually investigate IGF-1 LR3 for cell proliferation, anabolic signaling, glucose uptake, and tissue-growth pathways. Because it acts downstream of growth-related signaling, it should be discussed carefully and scientifically, without implying that it is an approved product for muscle gain or performance use.